Pfizer (PFE)
(Delayed Data from NYSE)
$26.00 USD
+0.61 (2.40%)
Updated Apr 19, 2024 04:00 PM ET
After-Market: $25.93 -0.07 (-0.27%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth C Momentum C VGM
Price, Consensus and EPS Surprise
PFE 26.00 +0.61(2.40%)
Will PFE be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for PFE based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for PFE
Here is What to Know Beyond Why Pfizer Inc. (PFE) is a Trending Stock
Why the Market Dipped But Pfizer (PFE) Gained Today
PFE: What are Zacks experts saying now?
Zacks Private Portfolio Services
Pharma Stock Roundup: JNJ to Buy Shockwave Medical, Other Pipeline & Regulatory News
Will Novavax's (NVAX) Strategic Reshaping Curb Cash Burn?
Will Pfizer's (PFE) New Drugs Provide a Boost to 2024 Sales?
Other News for PFE
Morning Brew: Tech Giants Lead Market Movements Amid Key Announcements
Unveiling Pfizer's Potent Cocktail: Key Drivers Of Free Cash Flow Growth
Catalyst Watch: Tesla, Boeing and General Motors brace for earnings fireworks
Rosy Debuts New Content Focused on Menopause and Migraine Education
December 20th Options Now Available For Pfizer (PFE)